Cortina Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-187,089
Closed -$14.2M 230
2016
Q1
$14.2M Buy
187,089
+2,191
+1% +$162K 0.64% 48
2015
Q4
$14.9M Buy
184,898
+26,903
+17% +$1.94M 0.67% 42
2015
Q3
$10M Sell
157,995
-556
-0.4% -$39.9K 0.46% 76
2015
Q2
$11.2M Sell
158,551
-88,658
-36% -$6.56M 0.49% 81
2015
Q1
$19.6M Sell
247,209
-48,640
-16% -$3.59M 0.85% 31
2014
Q4
$18.8M Buy
295,849
+20,989
+8% +$1.32M 0.83% 35
2014
Q3
$16.4M Sell
274,860
-71,614
-21% -$4.1M 0.7% 45
2014
Q2
$18.5M Buy
+346,474
New +$19M 0.7% 43

Other funds holding CRL

Cortina Asset Management's CRL Position: Q2 2016 in Review

Cortina Asset Management sold out of Charles River Laboratories (CRL) in Q2 2016, closing a stake of 187,089 shares — an estimated $14.2M sold.

Cortina Asset Management first reported a position in CRL in Q2 2014 and held it in 8 quarters. The position peaked at $19.6M in Q1 2015. 286 funds tracked by Wall St. Rank hold CRL as of Q2 2016.

  • Cortina Asset Management reported no remaining Charles River Laboratories position as of Q2 2016 after selling out during the quarter.
  • Cortina Asset Management sold 187,089 Charles River Laboratories shares in Q2 2016, an estimated $14.2M.
  • Cortina Asset Management first reported a position in Charles River Laboratories in Q2 2014 and held it in 8 quarters.
  • Cortina Asset Management's Charles River Laboratories position peaked at $19.6M in Q1 2015.
  • 286 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2016.

Based on Cortina Asset Management's 13F filing for Q2 2016, filed 11 Aug 2016.